TVTX logo

Travere Therapeutics, Inc. (TVTX) Gross profit

Annual gross profit:

$181.88M+$86.62M(+90.93%)
December 31, 2024

Summary

  • As of today (September 16, 2025), TVTX annual gross profit is $181.88 million, with the most recent change of +$86.62 million (+90.93%) on December 31, 2024.
  • During the last 3 years, TVTX annual gross profit has fallen by -$12.21 million (-6.29%).
  • TVTX annual gross profit is now -6.29% below its all-time high of $194.09 million, reached on December 31, 2021.

Performance

TVTX Gross profit Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherTVTXincome statement metrics

quarterly gross profit:

$98.91M+$34.66M(+53.95%)
June 30, 2025

Summary

  • As of today (September 16, 2025), TVTX quarterly gross profit is $98.91 million, with the most recent change of +$34.66 million (+53.95%) on June 30, 2025.
  • Over the past year, TVTX quarterly gross profit has increased by +$57.20 million (+137.14%).
  • TVTX quarterly gross profit is now at all-time high.

Performance

TVTX quarterly gross profit Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherTVTXincome statement metrics

TTM gross profit:

$273.34M+$57.20M(+26.47%)
June 30, 2025

Summary

  • As of today (September 16, 2025), TVTX TTM gross profit is $273.34 million, with the most recent change of +$57.20 million (+26.47%) on June 30, 2025.
  • Over the past year, TVTX TTM gross profit has increased by +$148.66 million (+119.24%).
  • TVTX TTM gross profit is now at all-time high.

Performance

TVTX TTM gross profit Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherTVTXincome statement metrics

Gross profit Formula

Gross Profit = Revenue − Cost Of Goods Sold

TVTX Gross profit Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+90.9%+137.1%+119.2%
3 y3 years-6.3%+124.8%+43.6%
5 y5 years+21.5%+137.5%+70.9%

TVTX Gross profit Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-6.3%+115.7%at high+416.0%at high+163.1%
5 y5-year-6.3%+115.7%at high+416.0%at high+163.1%
alltimeall time-6.3%>+9999.0%at high>+9999.0%at high>+9999.0%

TVTX Gross profit History

DateAnnualQuarterlyTTM
Jun 2025
-
$98.91M(+53.9%)
$273.34M(+26.5%)
Mar 2025
-
$64.25M(+6.8%)
$216.13M(+18.8%)
Dec 2024
$181.88M(+90.9%)
$60.14M(+20.2%)
$181.87M(+20.9%)
Sep 2024
-
$50.03M(+20.0%)
$150.38M(+20.6%)
Jun 2024
-
$41.71M(+39.1%)
$124.67M(-1.7%)
Mar 2024
-
$29.99M(+4.7%)
$126.77M(+8.4%)
Dec 2023
$95.26M(+13.0%)
$28.64M(+17.7%)
$116.90M(+8.8%)
Sep 2023
-
$24.33M(-44.5%)
$107.43M(+3.4%)
Jun 2023
-
$43.80M(+117.7%)
$103.90M(-0.2%)
Mar 2023
-
$20.12M(+5.0%)
$104.11M(-15.5%)
Dec 2022
$84.32M(-56.6%)
$19.17M(-7.9%)
$123.24M(-19.1%)
Sep 2022
-
$20.81M(-52.7%)
$152.37M(-19.9%)
Jun 2022
-
$44.01M(+12.1%)
$190.31M(-1.2%)
Mar 2022
-
$39.26M(-18.7%)
$192.65M(-0.3%)
Dec 2021
$194.09M(+14.3%)
$48.29M(-17.8%)
$193.20M(+2.8%)
Sep 2021
-
$58.75M(+26.8%)
$187.86M(+8.6%)
Jun 2021
-
$46.35M(+16.4%)
$173.04M(+2.8%)
Mar 2021
-
$39.81M(-7.3%)
$168.34M(-0.6%)
Dec 2020
$169.76M(+13.4%)
$42.95M(-2.2%)
$169.28M(+2.0%)
Sep 2020
-
$43.93M(+5.5%)
$165.99M(+3.8%)
Jun 2020
-
$41.65M(+2.2%)
$159.92M(+1.8%)
Mar 2020
-
$40.74M(+2.7%)
$157.16M(+4.6%)
Dec 2019
$149.70M(+6.4%)
$39.67M(+4.8%)
$150.24M(+1.5%)
Sep 2019
-
$37.85M(-2.7%)
$148.02M(+2.0%)
Jun 2019
-
$38.89M(+15.0%)
$145.12M(+2.3%)
Mar 2019
-
$33.82M(-9.7%)
$141.89M(+1.0%)
Dec 2018
$140.69M(+5.4%)
$37.46M(+7.2%)
$140.54M(+0.7%)
Sep 2018
-
$34.95M(-2.0%)
$139.62M(+0.1%)
Jun 2018
-
$35.66M(+9.8%)
$139.47M(+1.4%)
Mar 2018
-
$32.47M(-11.1%)
$137.49M(+2.9%)
Dec 2017
$133.53M
$36.53M(+5.0%)
$133.65M(+3.6%)
Sep 2017
-
$34.80M(+3.3%)
$129.05M(+5.3%)
Jun 2017
-
$33.68M(+17.7%)
$122.53M(+4.6%)
DateAnnualQuarterlyTTM
Mar 2017
-
$28.63M(-10.4%)
$117.17M(+3.8%)
Dec 2016
$112.90M(+33.9%)
$31.94M(+13.0%)
$112.90M(+5.7%)
Sep 2016
-
$28.28M(-0.2%)
$106.83M(+4.6%)
Jun 2016
-
$28.32M(+16.3%)
$102.17M(+9.3%)
Mar 2016
-
$24.36M(-5.8%)
$93.47M(+10.7%)
Dec 2015
$84.31M(+279.3%)
$25.87M(+9.6%)
$84.43M(+17.9%)
Sep 2015
-
$23.62M(+20.3%)
$71.62M(+31.9%)
Jun 2015
-
$19.62M(+28.1%)
$54.31M(+40.1%)
Mar 2015
-
$15.32M(+17.3%)
$38.76M(+66.1%)
Dec 2014
$22.23M(<-9900.0%)
$13.06M(+107.3%)
$23.34M(+128.3%)
Sep 2014
-
$6.30M(+54.4%)
$10.22M(+201.5%)
Jun 2014
-
$4.08M(-4172.2%)
$3.39M(-374.5%)
Mar 2014
-
-$100.20K(+76.1%)
-$1.24M(+4.0%)
Dec 2013
-$216.00K(+72.9%)
-$56.90K(-89.3%)
-$1.19M(-5.4%)
Sep 2013
-
-$532.60K(-2.3%)
-$1.25M(+73.7%)
Jun 2013
-
-$545.30K(+944.6%)
-$722.40K(+307.9%)
Mar 2013
-
-$52.20K(-58.2%)
-$177.10K(+41.8%)
Dec 2012
-$124.90K(<-9900.0%)
-$124.90K(<-9900.0%)
-$124.90K(<-9900.0%)
Nov 2011
-
$0.00(0.0%)
$0.00(0.0%)
Aug 2011
-
$0.00(0.0%)
$0.00(0.0%)
May 2011
-
$0.00(0.0%)
$0.00(0.0%)
Feb 2011
$0.00(0.0%)
$0.00(0.0%)
$0.00(0.0%)
Nov 2010
-
$0.00(0.0%)
$0.00(0.0%)
Aug 2010
-
$0.00(0.0%)
$0.00(0.0%)
May 2010
-
$0.00(0.0%)
$0.00(0.0%)
Feb 2010
$0.00(0.0%)
$0.00(0.0%)
$0.00(0.0%)
Nov 2009
-
$0.00(0.0%)
$0.00(0.0%)
Aug 2009
-
$0.00(0.0%)
$0.00(0.0%)
May 2009
-
$0.00(0.0%)
$0.00(0.0%)
Feb 2009
$0.00(0.0%)
$0.00(0.0%)
$0.00(0.0%)
Nov 2008
-
$0.00(0.0%)
$0.00(0.0%)
Aug 2008
-
$0.00(0.0%)
$0.00(0.0%)
May 2008
-
$0.00
$0.00
Feb 2008
$0.00
-
-

FAQ

  • What is Travere Therapeutics, Inc. annual gross profit?
  • What is the all time high annual gross profit for Travere Therapeutics, Inc.?
  • What is Travere Therapeutics, Inc. annual gross profit year-on-year change?
  • What is Travere Therapeutics, Inc. quarterly gross profit?
  • What is the all time high quarterly gross profit for Travere Therapeutics, Inc.?
  • What is Travere Therapeutics, Inc. quarterly gross profit year-on-year change?
  • What is Travere Therapeutics, Inc. TTM gross profit?
  • What is the all time high TTM gross profit for Travere Therapeutics, Inc.?
  • What is Travere Therapeutics, Inc. TTM gross profit year-on-year change?

What is Travere Therapeutics, Inc. annual gross profit?

The current annual gross profit of TVTX is $181.88M

What is the all time high annual gross profit for Travere Therapeutics, Inc.?

Travere Therapeutics, Inc. all-time high annual gross profit is $194.09M

What is Travere Therapeutics, Inc. annual gross profit year-on-year change?

Over the past year, TVTX annual gross profit has changed by +$86.62M (+90.93%)

What is Travere Therapeutics, Inc. quarterly gross profit?

The current quarterly gross profit of TVTX is $98.91M

What is the all time high quarterly gross profit for Travere Therapeutics, Inc.?

Travere Therapeutics, Inc. all-time high quarterly gross profit is $98.91M

What is Travere Therapeutics, Inc. quarterly gross profit year-on-year change?

Over the past year, TVTX quarterly gross profit has changed by +$57.20M (+137.14%)

What is Travere Therapeutics, Inc. TTM gross profit?

The current TTM gross profit of TVTX is $273.34M

What is the all time high TTM gross profit for Travere Therapeutics, Inc.?

Travere Therapeutics, Inc. all-time high TTM gross profit is $273.34M

What is Travere Therapeutics, Inc. TTM gross profit year-on-year change?

Over the past year, TVTX TTM gross profit has changed by +$148.66M (+119.24%)
On this page